Melissa Nancy Brancati, NP

Melissa Brancati practices at St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre.

Melissa Brancati's NPI, 1295317253, was assigned on April 28, 2021. Melissa Brancati holds New York license 309998.

Melissa Brancati's primary practice is St. Francis Hospital & Heart Center, at 100 Port Washington Boulevard, Roslyn, NY 11576 in Nassau County. The practice phone is (516) 562-6000.

Melissa Brancati's primary practice is St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre. The medical group on file is Cardiac Interventional Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Melissa Brancati practices. Vendor and product names are available with a free account.

Cardiovascular disease is Melissa Brancati's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Melissa Brancati is licensed in New York.

CMS data shows 347 Medicare services from Melissa Brancati across 3 procedure codes in 2024, for 208 Medicare patients. Medicare paid $22,807 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 208 Medicare patients who saw Melissa Brancati in 2024. The largest group is 75 to 84, with 84 patients. 75% of them have heart failure, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Melissa Brancati's median patient age at 77, with 35% women.

In 2024, Melissa Brancati wrote 682 Medicare Part D claims for 236 patients. 82% of them were for generic drugs. CMS names the drug for 519 of them, across 15 drugs with 11 or more claims each, at $92,740 in total drug cost. In 2023, CMS named 664 claims across 18 drugs.

Melissa Brancati accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 21 general payments to Melissa Brancati from 10 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 67% of the total. Boston Scientific Corporation paid the most, $1,570.